Allspring Global Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $57.2M | Buy |
126,540
+18,011
| +17% | +$8.14M | 0.1% | 256 |
|
2025
Q1 | $52.6M | Buy |
108,529
+11,903
| +12% | +$5.77M | 0.09% | 275 |
|
2024
Q4 | $39.2M | Sell |
96,626
-139,700
| -59% | -$56.7M | 0.06% | 356 |
|
2024
Q3 | $110M | Buy |
236,326
+37,399
| +19% | +$17.4M | 0.17% | 138 |
|
2024
Q2 | $93.2M | Sell |
198,927
-32,529
| -14% | -$15.2M | 0.15% | 155 |
|
2024
Q1 | $96.8M | Buy |
231,456
+18,113
| +8% | +$7.57M | 0.15% | 158 |
|
2023
Q4 | $86.8M | Sell |
213,343
-27,711
| -11% | -$11.3M | 0.14% | 169 |
|
2023
Q3 | $83.8M | Sell |
241,054
-156,611
| -39% | -$54.5M | 0.15% | 167 |
|
2023
Q2 | $140M | Sell |
397,665
-9,598
| -2% | -$3.38M | 0.22% | 104 |
|
2023
Q1 | $128M | Sell |
407,263
-45,307
| -10% | -$14.3M | 0.21% | 107 |
|
2022
Q4 | $131M | Sell |
452,570
-24,631
| -5% | -$7.11M | 0.22% | 108 |
|
2022
Q3 | $138M | Buy |
477,201
+95,856
| +25% | +$27.8M | 0.24% | 89 |
|
2022
Q2 | $107M | Buy |
381,345
+68,586
| +22% | +$19.3M | 0.18% | 148 |
|
2022
Q1 | $81.6M | Sell |
312,759
-22,846
| -7% | -$5.96M | 0.1% | 263 |
|
2021
Q4 | $73.7M | Buy |
+335,605
| New | +$73.7M | 0.08% | 313 |
|